Targeting bcl-2 gene to delay androgen-independent progression and enhance chemosensitivity in prostate cancer using antisense bcl-2 oligodeoxynucleotides-Reference-Cited by-同舟云学术

Targeting bcl-2 gene to delay androgen-independent progression and enhance chemosensitivity in prostate cancer using antisense bcl-2 oligodeoxynucleotides

Published:1999-12 Issue:6 Volume:54 Page:36-46
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Gleave Martin E,Miayake Hideaki,Goldie Jim,Nelson Colleen,Tolcher Anthony

Publisher

Elsevier BV

Subject

Urology

Reference33 articles.

1. Overview of phase III trials on combined androgen treatment in patients with metastatic prostate cancer;Denis;Cancer,1993

2. Management of hormone refractory prostate cancer;Oh;J Urol,1998

3. Effects of androgen withdrawal on the stem cell composition of the Shionogi carcinoma;Bruchovsky;Cancer Res,1990

4. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer;McDonnell;Cancer Res,1992

5. Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone-refractory human prostate cancers;Colombel;Am J Pathol,1993

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bcl-2 pathway inhibition in solid tumors: a review of clinical trials;Clinical and Translational Oncology;2023-01-13

2. The Role of BCL-2 Proteins in the Development of Castration-resistant Prostate Cancer and Emerging Therapeutic Strategies;American Journal of Clinical Oncology;2021-05-12

3. Implications of Bcl-2 and its interplay with other molecules and signaling pathways in prostate cancer progression;Expert Opinion on Therapeutic Targets;2017-08-23

4. Bcl-2 expression is a poor predictor for hepatocellular carcinoma prognosis of andropause-age patients;Cancer Biology & Medicine;2016

5. The hallmarks of castration-resistant prostate cancers;Cancer Treatment Reviews;2015-07